Life Science

Profit with Pharmaceuticals

Austria’s entire pharmaceutical market will grow rapidly within the next few years. More than 65 industrial pharmaceutical companies are active in the innovation location Austria. Multinational groups such as Sandoz, Eli Lilly and Roche not only have production sites here, but also research and competence centers. They also benefit from Austria’s excellent human capital, as well as its proximity to the Central and Eastern European markets.

Competency in Cancer Research

Austria is a pioneer in cancer research. Oncotyrol, the first K1 Center of Excellence in the COMET funding program, will dedicate the next four years to researching and developing top-quality technologies to fight cancer, looking to find individual, custom-made concepts for therapies and medicine treatment concepts. In addition, several businesses in the Life Science Cluster Vienna Region (LISA VR) are providing many promising techniques to develop therapeutic agents to combat cancer.